| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 09/12/2012 | CN102666500A Seven-membered ring compound and pharmaceutical use therefor |
| 09/12/2012 | CN102665715A Compositions for treatment of cystic fibrosis and other chronic diseases |
| 09/12/2012 | CN102665708A A combination for the treatment of osteoarthritis |
| 09/12/2012 | CN102665705A New combination of active ingredients containing a non steroidal anti inflammatory drug and a colchicoside derivative |
| 09/12/2012 | CN102660551A VHH (variable domain of heavy chain of heavy-chain antibody) antibody gene derived from anti-CyPA (CyclophilinA) animal of family Camelidae, encoded polypeptide, and application thereof |
| 09/12/2012 | CN102659945A Anti-C5aR antibodies and uses thereof |
| 09/12/2012 | CN102659944A IL-18 binding proteins |
| 09/12/2012 | CN102659938A Glucagon-like-peptide-2 (GLP-2) analogues |
| 09/12/2012 | CN102659840A Imidazole diphosphonie acid compound and pharmaceutically-acceptable salt and medicinal application thereof |
| 09/12/2012 | CN102659569A Royal jelly acid calcium, and health product for antiatherosclerosis and antiosteoporosis prepared from royal jelly acid calcium and vitamin K2 |
| 09/12/2012 | CN102657842A Medicinal composition with function of increasing bone density and application thereof |
| 09/12/2012 | CN102657835A Composition and medical liquor for treatment of high blood pressure/rheumatoid arthritis and preparation method and application of composition and medical liquor |
| 09/12/2012 | CN102657825A Rheumatic pain-relieving medicine used for treating rheumatic arthritis and rheumatoid arthritis and preparation method thereof |
| 09/12/2012 | CN102657824A Medicine used for treating fracture |
| 09/12/2012 | CN102657817A Traditional Chinese medical composition for treatment of cervical spondylosis |
| 09/12/2012 | CN102657792A Traditional Chinese medicine extract for treating degenerative joint diseases and preparation method thereof |
| 09/12/2012 | CN102657771A Medicament for osteoporosis treatment |
| 09/12/2012 | CN102657762A Osteopathia healing capsules |
| 09/12/2012 | CN102657761A Patch for treating rheumatoid arthritis and preparation method for patch |
| 09/12/2012 | CN102657751A Medicament for treating osteoporosis |
| 09/12/2012 | CN102657737A Medicament for treating acute gouty arthritis |
| 09/12/2012 | CN102657736A Medicament composition for treating rheumatoid arthritis and preparation method of medicament composition |
| 09/12/2012 | CN102657734A Chinese medical herb pill for treating protrusion and bulging of cervical vertebra and lumbar vertebra and osteoproliferation |
| 09/12/2012 | CN102657710A Medicament for treating backache and lumbar disc herniation by renewing muscles and bones and method for preparing the same |
| 09/12/2012 | CN102657660A Application of total triterpenes in preparing drugs inhibiting angiogenesis |
| 09/12/2012 | CN102657656A Composition and methods for modulating a kinase cascade |
| 09/12/2012 | CN102657647A Application of IC-4 in antiangiogenesis |
| 09/12/2012 | CN102145136B Chinese medical meridian physiotherapy liquid and preparation method and application thereof |
| 09/12/2012 | CN102145106B Chinese medical composition for treating osteoporosis and granular formulation capable of tonifying kidney and invigorating blood circulation |
| 09/12/2012 | CN102058580B New application of 15-oxospiramilactone for inhibition of Wnt signal path |
| 09/12/2012 | CN102028846B Traditional Chinese medicinal composition for treating osteoporosis |
| 09/12/2012 | CN102018792B Traditional Chinese medicine for treating ankylosing spondylitis |
| 09/12/2012 | CN101869699B Preparation process of bone peptide soft capsule |
| 09/12/2012 | CN101781347B Polymorphic substances of decitabine and medical compositions |
| 09/12/2012 | CN101760446B Method for preparing monocyte type stem cell and application |
| 09/12/2012 | CN101715956B Multifunctional health juice with stable effective ingredients and processing method thereof |
| 09/11/2012 | US8263647 Treatment of sleep disturbances |
| 09/11/2012 | US8263637 Methods for treatment of multiple myeloma using cyclopropane carboxylic acid {2-[(is)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1 h-isoindol-4-yl}-amide |
| 09/11/2012 | US8263597 Indazole compounds as CCR1 receptor antagonists |
| 09/11/2012 | US8263546 Prevention and treatment of osteoarthritis |
| 09/11/2012 | US8263121 Solid pharmaceutical preparation |
| 09/11/2012 | US8263118 Bioresorbable fillers constituted by phospholipid liposomes and hyaluronic acid and/or the derivatives thereof |
| 09/11/2012 | US8263070 Using immunoglobulin specific to receptor for OX-2 membrane glycoprotein as diagnostic and therapeutic tool for treatment and prevention of asthma, infection, allergies, skin and cell proliferative disorders |
| 09/11/2012 | CA2558506C Mtp inhibiting aryl piperidines or piperazines substituted with 5-membered heterocycles |
| 09/11/2012 | CA2474402C Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds |
| 09/11/2012 | CA2451577C Gene delivery vectors with cell type specificity for mesenchymal stem cells |
| 09/11/2012 | CA2257247C Novel protein binding to osteoclastogenesis inhibitory factor and process for producing the same |
| 09/07/2012 | WO2012119102A2 Homeopathic therapeutic method and compositions |
| 09/07/2012 | WO2012118309A2 Pyrazole derivatives, preparation method thereof, and composition for preventing and treating osteoporosis containing same |
| 09/07/2012 | WO2012118194A1 Pre-filled syringe filling syringe having resin barrel with aqueous solution containing hyaluronic acid or salt thereof |
| 09/07/2012 | WO2012118192A1 Aqueous solution containing hyaluronic acid or salt thereof |
| 09/07/2012 | WO2012118191A1 Aqueous solution containing hyaluronic acid or salt thereof |
| 09/07/2012 | WO2012118190A1 Aqueous solution containing hyaluronic acid or salt thereof |
| 09/07/2012 | WO2012118154A1 Novel vitamin d receptor modulator with partial agonist activity |
| 09/07/2012 | WO2012118124A1 Novel chemokine receptor antagonist |
| 09/07/2012 | WO2012118097A1 Cell sheet having hyaluronic acid production ability and method for producing same |
| 09/07/2012 | WO2012117097A1 Biaryl derivatives as selective 17beta-hydroxysteroid dehydrogenase type 2 inhibitors |
| 09/07/2012 | WO2012117012A1 Composition for nutrition purposes |
| 09/07/2012 | WO2012116439A1 Biomaterial, method for making the biomaterial and uses of the same |
| 09/07/2012 | WO2012066485A3 Agave fructans compositions and their use in mineral absorption |
| 09/07/2012 | WO2012010883A3 Pharmaceutical depot for 5-fluoro-2 [ [ (1s) -1- (5-fluoro-2-pyridyl)ethyl]amino]-6-[(5-isopropoxy-1h-pyrazol-3-yl)amino]pyridine-3-carbonitrile |
| 09/07/2012 | CA2831978A1 Biaryl derivatives as selective 17beta-hydroxysteroid dehydrogenase type 2 inhibitors |
| 09/07/2012 | CA2828883A1 Homeopathic therapeutic method and compositions |
| 09/07/2012 | CA2828016A1 Biomaterial, method for making the biomaterial and uses of the same |
| 09/07/2012 | CA2828000A1 Bispecific binding agents |
| 09/06/2012 | US20120225937 Crystalline forms and processes for the preparation of pg12 receptor agonists |
| 09/06/2012 | US20120225904 New 7-Phenyl-[1,2,4]triazolo[4,3-a]Pyridin-3(2H)-One Derivatives |
| 09/06/2012 | US20120225889 Use of macrocyclic lactone derivatives for the treatment of inflammatory disorders |
| 09/06/2012 | US20120225883 Compounds for inflammation and immune-related uses |
| 09/06/2012 | US20120225882 Selective hydroxamate based mmp inhibitors |
| 09/06/2012 | US20120225879 Substituted 5-imino-1,2,4-thiadiazoles that can be used to treat neurodegenerative diseases |
| 09/06/2012 | US20120225876 8-azabicyclo[3.2.1]octane-8-carboxamide derivative |
| 09/06/2012 | US20120225875 Heteroarylaminoquinolines as tgf-beta receptor kinase inhibitors |
| 09/06/2012 | US20120225861 6-O-Substituted Benzoxazole and Benzothiazole Compounds and Methods of Inhibiting CSF-1R Signaling |
| 09/06/2012 | US20120225857 Mst1 kinase inhibitors and methods of their use |
| 09/06/2012 | US20120225855 Triazolopyridine jak inhibitor compounds and methods |
| 09/06/2012 | US20120225852 Use of steroid compounds |
| 09/06/2012 | US20120225849 2-Methoxyestradiol (2-ME2) Prodrug with Enhanced Bioavailability for Prophylaxis or Treatment of Cancerous or Non-Cancerous Condition |
| 09/06/2012 | US20120225847 Squaric acid derivatives as inhibitors of the nicotinamide |
| 09/06/2012 | US20120225828 Melanocortin-1 Receptor-Specific Cyclic Peptides |
| 09/06/2012 | US20120225808 Pharmaceutical Composition for Preventing / Treating TRPV1 Activity-Related and Inflammation-Related Diseases or Conditions Containing Maillard Peptide Separated from Well-Aged Traditional Soy Sauce as Active Ingredient |
| 09/06/2012 | US20120225119 Therapeutic combination for painful medical conditions |
| 09/06/2012 | US20120225114 Modifying Macrophage Phenotype for Treatment of Disease |
| 09/06/2012 | US20120225097 Piperazinecarboxamide derivative useful as a modulator of fatty acid amide hydrolase (faah) |
| 09/06/2012 | US20120225096 Immunomodulation using placental stem cells |
| 09/06/2012 | US20120225088 Compositions and methods for treating cancer and other diseases |
| 09/06/2012 | US20120225069 Use of a compound for reducing the biological effectiveness of il-6 |
| 09/06/2012 | US20120225066 Therapeutic nuclease compositions and methods |
| 09/06/2012 | US20120225065 Anti-human il-21 monoclonal antibodies |
| 09/06/2012 | US20120225062 Novel kinase inhibitors |
| 09/06/2012 | US20120225057 Methods and compositions for the treatment of myeloproliferative diseases and other proliferative diseases |
| 09/06/2012 | US20120225053 Compositions and methods for the prevention and treatment of conditions associated with inflamation |
| 09/06/2012 | US20120225039 Tissue engineered cartilage, method of making same, therapeutic and cosmetic surgical applications using same |
| 09/06/2012 | US20120225032 Dimeric Alpha Interferon PEGylated Site-Specifically Shows Enhanced and Prolonged Efficacy in Vivo |
| 09/06/2012 | US20120225030 Uses of mammalian cytokine; related reagents |
| 09/06/2012 | US20120225018 Homeopathic therapeutic method and compositions |
| 09/06/2012 | US20120225012 Composition for hard tissue repair |
| 09/05/2012 | EP2495319A1 INTEGRIN alpha8beta1-SPECIFIC MONOCLONAL ANTIBODY |
| 09/05/2012 | EP2495315A1 Humanized recombinant uricase and mutants thereof |
| 09/05/2012 | EP2494990A1 Agent for regeneration and/or protection of nerves |